• Items
  • Login
  • Register

An Introduction to Biosimilar Product Regulation and Approval

Add to Cart
Back to Results
Recorded March 31, 2020 | On-Demand Webinar

Review background and definitions of biologic and biosimilar drugs and new drug application (NDAs) and biologics license application (BLAs). Discuss biosimilar pathways to market and application contents. Learn about the types of meetings available to interact with FDA. Examine interchangeability standards and conditions of use.

This session was recorded as part of FDLI’s virtual Introduction to Biologics and Biosimilars Law and Regulation course in March 2020.

Assign Members : 
Members Assigned | Assign all contacts Unassign all contacts

  • All
  • Assigned
  • Unassigned
Add New Contact

Add New Contact





Cancel
Save

Assign Full Name Account Name Email Role
Total Records - Showing Page

Discounts and special pricing for additional items will be applied once you add the item to your cart.
Previous Next